2017 Cholesterol Heart Attack 
Dr. Paddy Barrett
FEBRUARY 14, 2025
“Cholesterol does not cause heart disease.“ “ “Statins do not prevent heart attacks.” In the middle of this hurricane of noise are people who just want to know what to do so they don’t have a heart attack at a young age. Cholesterol is an essential part of that process.
Dr. Paddy Barrett
DECEMBER 27, 2024
For every 20mmHg increase in systolic (Top Number) blood pressure, the risk of dying from a heart attack or stroke doubles 3. Non-HDL Cholesterol There is no ‘Good’ cholesterol on a standard cholesterol blood test. There really is only bad cholesterol. What is your Non-HDL cholesterol?
DAIC
JANUARY 23, 2024
3 Patients with ASCVD are at a higher risk for major adverse cardiovascular events (MACE) including heart attack or myocardial infarction (MI), stroke, and cardiovascular (CV) death.4 4 In the U.S. Historically I have witnessed patients with systemic inflammatory disorders, and I know how they affect the cardiovascular system.
Dr. Paddy Barrett
JUNE 21, 2024
Some groups will state that any heart events at less than 55 years of age for males and less than 65 for females define early heart disease. A heart attack in a 56-year-old male is early in anyone's books. However, the above age cut-offs give a good idea of what we consider the early presentation of heart disease.
DAIC
AUGUST 21, 2024
The results were calculated using a new, proposed risk prediction scale for heart failure specifically for American Indian adults. Type 2 diabetes was associated with a 74% increased risk of developing heart failure within 10 years; and High blood pressure increased the risk of developing heart failure at 10 years by 43%.
Dr. Malcolm Kendrick
OCTOBER 20, 2023
People at risk of cardiovascular disease would have their cholesterol levels checked. The aim is to reduce death and damage from nasty things such as heart attacks and strokes. With diabetes, the aim is also to reduce heart attacks and strokes… additionally kidney failure, and amputations, and blindness.
Dr. Anish Koka
JANUARY 18, 2023
Discovering discrepancies in a major published trial from the pharma-academic complex would be a boost to those seeking to force trial data to be public, and that is exactly what a group of investigators attempted to do with a major cholesterol lowering trial published in 2017. Cholesterol lowering is big business.
Expert insights. Personalized for you.
112 
Let's personalize your content